Friday 23 May 13:00 - 14:00
Building on firm foundations: Optimizing clinical benefit with Lucentis
Moderator: Ursula Schmidt-Erfurth

13.00	U Schmidt-Erfurth AUSTRIA Welcome and introduction
13.05	C Prünte AUSTRIA Lucentis in AMD: Reviewing the evidence base for clinical benefit
13.25	U Schmidt-Erfurth AUSTRIA Optimizing treatment response with guided dosing for Lucentis
13.40	P Massin FRANCE New horizons: Latest clinical developments with Lucentis
13.50	ALL Panel discussion
14.00	U Schmidt-Erfurth AUSTRIA Closing remarks
	Sponsored By

Friday 23 May 13:00 - 14:00
Next Generation Retinal Imaging: Multi-Modality Tracking Laser Tomography
Moderator: F. Holz, GERMANY

13.00	F. Holz GERMANY Introduction
13.05	S. Wolf SWITZERLAND Spectralis Technology: Benefits of real time eye tracking in multi-modality cSLO / SD-OCT imaging
13.20	F. Holz GERMANY Spectralis applications in macular diseases - a new horizon
13.35	G. Coscas FRANCE Angiography combined with SD-OCT imaging for diagnosis and treatment follow-up of vascularised PED
13.50	ALL Panel Discussion
14.00	F. Holz GERMANY Closing remarks
	Sponsored By

Friday 23 May 18:00 - 19:30
Trends in Medical and Surgical Retina
Moderator: B. Corcostegui SPAIN

	B. Corcostegui SPAIN Trends in Medical and Surgical Retina
	A. Augustin GERMANY Rationale for combination treatments in medical and surgical retina
	J.F. Korobelnick FRANCE Pearls on how to shift from 20G surgery to Micro Incision Vitrectomy Surgery
	S. Rizzo ITALY Proper Protocol Importance: Cost and Effectiveness of 20G Surgery versus Micro-Incisional Vitrectomy Surgery
	B. Corcostegui SPAIN Small Gauge Dissection Technique
	Z. Tomic SWEDEN 23G surgery in complicated cases
	K. Packo USA Using Fluidics to Your Best Advantage During Vitrectomy
	Conclusions and panel discussion
	Sponsored By
	Followed by a light reception

Saturday 24 May 13:00 - 14:00
Management of Patients with Macular Edema
Moderator: J Haller & F Bandello

	Intro and Welcome
	W Drexler UK High Resolution Imaging technology for ME and other retinal diseases
	J Haller USA Pathophysiology of DME and historical treatment
	J Ambati USA Therapy in DME – the molecular basis
	B Kupperman USA Therapy in DME - steroids
	F Bandello ITALY Therapy in DME – anti VEGF and others
	A Augustin GERMANY Therapy in DME – Combination or triple?
	Sponsored By

Saturday 24th May 13:00 - 14:00
THE GEUDER LUNCH SYMPOSIUM: INNOVATION IN RETINAL SURGERY
Moderator: S. Binder, AUSTRIA

	Dr. Heimann UK Siluron 2000: Chances for a new non-emulsifying long-term tamponade
	Dr. Rizzo ITALY Heavy Liquids: Complications and solution management
	Prof. Öncel TURKEY Brilliant Peel: New non-toxic dye for selective ILM staining
	Prof. Kampik GERMANY Perspectives of 23 gauge surgery, presentation of Ergoline instruments
	Prof. Lohmann GERMANY High-speed vitrectomy
	Sponsored By

Saturday 24th May 18:00 - 19:30
Maximising Safety and Efficacy in the Treatment of Wet AMD
Moderator: J. Cunha-Vaz, PORTUGAL

	J. Cunha-Vaz, PORTUGAL Welcome & Introduction
	D. Shima UK VEGF function in ocular health and disease – implications for therapeutic intervention in wet AMD
	J. Waltenberger THE NETHERLANDS Wet AMD: anti-VEGF treatments in an elderly population
	S. Sivaprasad UK Pegaptanib Sodium: “real life” experience in Europe
	J. J. Wroblewski, USA V.I.S.I.O.N. – Long-term safety update
	Sponsored By